Takeda’s Patent Infringement Suit Not Antitrust-Proof
Law360 (December 20, 2018, 8:19 PM EST) -- Patent infringement lawsuits challenging generic drug applications aren’t automatically immune from antitrust claims, a New Jersey federal judge ruled Wednesday, refusing to toss counterclaims accusing Takeda Pharmaceutical Co. Ltd. of trying...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
